ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 717

Dental Health in Systemic Sclerosis Patients Risk Factors and Comorbidities

Sabrina Paolino 1, Francesco Cattelan 2, Schenone Carlotta 3, Alberto Sulli 4, Andrea Casabella 5, Carmen Pizzorni 1 and Maurizio Cutolo6, 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genoa, Italy, Genoa, Italy, 2Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS Polyclinic Hospital San Martino, University of Genoa, Genoa, Italy, 3Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genoa, Italy, genova, Liguria, Italy, 4Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Genoa, Italy, 51 Research Laboratory and Academic Division of the Clinical Rheumatology Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genoa, Italy, Genoa, Italy, 6Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Genoa, Italy

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Systemic sclerosis, tbs and gums

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Background: Systemic sclerosis (SSc) is a rare multisystemic autoimmune disease characterized by microvascular damage and progressive fibrosis of skin and internal organs. Global oral health in SSc may depend by skin fibrosis of oral facial region or masticatory apparatus and quality of bone that is sustaining dentition (1). Trabecular Bone Score (TBS) analysis provides an indirect measurement of microarchitecture and get information about bone quality in several rheumatic diseases such as SSc (2).

Objectives: The aim of the study was to evaluate the most frequent dental/oral alterations in a cohort of SSc patients and the relationship between dental loose and quality of bone evaluated by TBS.

Methods: 32 patients, fulfilling the ACR/EULAR 2013 criteria for SSc underwent a dual-energy X-ray absorptiometry scan (DXA) to evaluate bone mineral density and TBS. All patient performed a standard questionnaire regarding dental health

Results: Patients were 5 men (16%), 27 women (84%), mean age 60.3+8.7 years, disease duration from the first Raynaud symptoms was 13.2+4.5 years. All patients came from urban environment: 65.6% affected by limited SSc (lSSc ) and 34.4% by diffuse SSc (dSSc). Most of patients were taking immunosoppressive drugs (MTX 15%, MMF 32%, previous cyclophosfamide treatment 25%, cyclosporine 13%, RTX 6%) and 28 % were treated with only symptomatic drugs (i.e. vasodilators). Nobody was treated with bone antiresorptive drugs (bisphosphonates). Smokers were 19%.

The most frequent oral/dental alterations observed were: oral ulcers 31.3%; painful gums 46.8%; bleeding gums 37.5%; loos teeth 56.3%; dentures 66%; halitosis 46,8%; xerostomia 53.1 (sicca syndrome); swollen gums 25%; receding gums 59%; dental caries 65.6%; cewing issues 28.1%; microstomia 46.9%. The clinical evaluation looking at risk factors found: gastrointestinal involvement with dysmotility and disfagia (31%) and “claw hand” with difficult handgrip and related limited teeth brushing (19%). Most of patients (67%) presented low bone mass and osteopenia, only one case was diagnosed as true osteoporosis. Of note, no statistically differences in TBS were reported between patients with or without dental loose (1.276±0.08 vs 1.19±0.08 P=0.70).

Conclusion: SSc is associated with poor dental health with high prevalence of dental loose. Bone quality assessed by TBS do not seems to influence the unstable dentition and teeth loose; most probably the mechanism is related to ischemic bone area induced by microangiopathy as recently reported in literature (3).

1. Jung S et al. Oral Dis. 2017;23(4):424–439. 2. Ruaro B, et al. Clin Rheumatol. 2018 Nov;37(11):3057-3062. 3. Puzio A et al. Adv Clin Exp Med 2019;28(4):547-554


Disclosure: S. Paolino, None; F. Cattelan, None; S. Carlotta, None; A. Sulli, None; A. Casabella, None; C. Pizzorni, None; M. Cutolo, Boehringer, Actelion, Celgene, Bristol-Mayer Squibb, 2.

To cite this abstract in AMA style:

Paolino S, Cattelan F, Carlotta S, Sulli A, Casabella A, Pizzorni C, Cutolo M. Dental Health in Systemic Sclerosis Patients Risk Factors and Comorbidities [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/dental-health-in-systemic-sclerosis-patients-risk-factors-and-comorbidities/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dental-health-in-systemic-sclerosis-patients-risk-factors-and-comorbidities/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology